A Phase I/II Study of Intraperitoneal Paclitaxel in Patients With Metastatic Appendiceal Adenocarcinoma
Conditions: Metastatic Appendiceal Adenocarcinoma; Intraperitoneal Paclitaxel Interventions: Drug: Dexamethasone; Drug: Diphenhydramine; Drug: Famotidine; Drug: Paclitaxel Sponsors: M.D. Anderson Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 15, 2024 Category: Research Source Type: clinical trials
Donor Immune Cells (TGFbi NK Cells) and Isatuximab for the Treatment of Relapsed or Refractory Multiple Myeloma
Conditions: Recurrent Multiple Myeloma; Refractory Multiple Myeloma Interventions: Procedure: Biospecimen Collection; Procedure: Bone Marrow Aspiration and Biopsy; Drug: Cyclophosphamide; Drug: Dexamethasone; Procedure: Echocardiography; Biological: Isatuximab; Other: Questionnaire Administration; Biological: Universal Donor Expanded TGF-beta-imprinted NK Cells Sponsors: Elvira Umyarova; Sanofi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2024 Category: Research Source Type: clinical trials
Optimize First-line Treatment for AL Amyloidosis With t (11; 14)
Conditions: Amyloidosis; Systemic; AL Amyloidosis Interventions: Drug: Daratumumab; Drug: Bortezomib; Drug: Dexamethasone; Drug: Venetoclax Sponsors: Jin Lu, MD Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials
Phase III Clinical Trial to Evaluate the Neurological Effects of EryDex in Subjects With A-T (NEAT)
Conditions: Ataxia Telangiectasia Interventions: Drug: Dexamethasone sodium phosphate; Other: Placebo Sponsors: Erydel; Biotrial Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials
To Evaluate the Effects of EryDex in Patients With A-T
Conditions: Ataxia Telangiectasia Interventions: Drug: Dexamethasone sodium phosphate; Other: Placebo Sponsors: Erydel; Biotrial Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials
Subclinical Primary Aldosteronism in Diabetes At-Risk for Kidney Disease
Conditions: Type 2 Diabetes; Chronic Kidney Diseases Interventions: Diagnostic Test: Oral sodium suppression test; Diagnostic Test: Saline suppression test; Diagnostic Test: Captopril suppression test; Diagnostic Test: Dexamethasone suppression test; Diagnostic Test: Cosyntropin stimulation test Sponsors: Brigham and Women ' s Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 4, 2024 Category: Research Source Type: clinical trials
Phase 2 Study Applying MRD Techniques for Participants With Previously Untreated Multiple Myeloma Treated With D-VRd Prior To and After High-dose Therapy Followed by ASCT - TAURUS
Conditions: Multiple Myeloma Interventions: Drug: Daratumumab; Drug: Bortezomib; Drug: Lenalidomide; Drug: Dexamethasone Sponsors: European Myeloma Network; Janssen Pharmaceutica Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 4, 2024 Category: Research Source Type: clinical trials
Establishment and Evaluation of Prenatal Prevention and Treatment Strategy for NARDS
Conditions: Acute Respiratory Distress Syndrome; Respiratory Distress Syndrome, Acute Interventions: Drug: Dexamethasone Sponsors: The Second Affiliated Hospital of Chongqing Medical University; University-Town Hospital of Chongqing Medical University; Children ' s Hospital of Chongqing Medical University; Chongqing Medical Center for Women and Children Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 3, 2024 Category: Research Source Type: clinical trials
Lateral Epicondylitis Extracorporeal Shock Wave Therapy, Ultrasound Iontophoresis
Conditions: Lateral Epicondylitis Interventions: Other: Extracorporeal shock wave group; Other: ultrasound group; Other: dexamethasone iontophoresis group Sponsors: P ınar Özge Başaran Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 3, 2024 Category: Research Source Type: clinical trials
Ultrasound-guided erector spinae plane block for perioperative analgesia in patients undergoing laparoscopic nephrectomies surgery: a randomized controlled trial
This study is a randomized controlled trial conducted at a single center, with 50 participants being randomized in a 1:1 ratio to either the ESPB group or the control group. The trial aims to investigate the efficacy of ESPB in patients diagnosed with kidney cancer who are scheduled for laparoscopic nephrectomy. The primary outcome measure is the total consumption of intraoperative sufentanil. Secondary outcomes include the VAS score at rest and during coughing at 1 h, 6 h, 12 h, 24 h, and 48 h after surgery; total intraoperative remifentanil consumption; the number of times rescue analgesia is required; and the incidence ...
Source: Trials - January 2, 2024 Category: Research Source Type: clinical trials
FeAsiBility of a Treatment Free Interval in Newly Diagnosed MM Patients Treated With Daratumumab-lenalidomide-dexamethasone (HOVON174MM)
Conditions: Multiple Myeloma Interventions: Drug: Daratumumab Injection; Drug: Dexamethasone; Drug: Lenalidomide capsule Sponsors: Stichting Hemato-Oncologie voor Volwassenen Nederland Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 1, 2024 Category: Research Source Type: clinical trials
Intraligamentary Injections and Post-endodontic Pain
Conditions: Pulpitis Interventions: Drug: Dexamethasone Sponsors: Jamia Millia Islamia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 1, 2024 Category: Research Source Type: clinical trials
Fixed Duration vs Continuous Daratumumab in Transplant Ineligible Older Adults With Newly Diagnosed Multiple Myeloma
Conditions: Multiple Myeloma Interventions: Drug: Daratumumab; Drug: Lenalidomide; Drug: Dexamethasone Sponsors: Canadian Cancer Trials Group; Canadian Institutes of Health Research (CIHR); Myeloma Canada Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 27, 2023 Category: Research Source Type: clinical trials
Systemic and Local Inflammatory Biomarkers in the Treatment of Refractory Diabetic Macular Edema
Conditions: Diabetic Macular Edema; Inflammation Interventions: Diagnostic Test: serum samples; Drug: dexamethasone implant versus ranibizumab Sponsors: Saglik Bilimleri Universitesi Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 21, 2023 Category: Research Source Type: clinical trials
Treatment Protocol for Newky Diagnosed Adult Ph Positive ALL
Conditions: Lymphoblastic Leukemia; Philadelphia-Positive ALL; Adult ALL Interventions: Drug: Vincristine; Drug: Dexamethasone; Drug: Imatinib; Drug: Cytarabine; Drug: Mercaptopurine; Drug: Methotrexate; Drug: Ponatinib; Procedure: allogeneic stem cell transplantation; Procedure: Total body irradiation; Drug: Cyclophosphamide; Drug: Fludarabine Sponsors: PETHEMA Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2023 Category: Research Source Type: clinical trials
